Report cover image

Urinary Tract Infection Testing Market by Type (Cystitis, Pyelonephritis, Urethritis), Test (Cystoscopy Urinary Tract Infection Testing, Kidney & Bladder Ultrasound Urinary Tract Infection Testing, Laboratory Test), End-Use - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 194 Pages
SKU # IRE18451353

Description

Urinary Tract Infection Testing Market by Type (Cystitis, Pyelonephritis, Urethritis), Test (Cystoscopy Urinary Tract Infection Testing, Kidney & Bladder Ultrasound Urinary Tract Infection Testing, Laboratory Test), End-Use - Global Forecast 2024-2030


The Urinary Tract Infection Testing Market size was estimated at USD 571.59 million in 2023 and expected to reach USD 630.24 million in 2024, at a CAGR 10.74% to reach USD 1,167.86 million by 2030.

Global Urinary Tract Infection Testing Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Urinary Tract Infection Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Urinary Tract Infection Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Urinary Tract Infection Testing Market, highlighting leading vendors and their innovative profiles. These include Accelerate Diagnostics, Inc., ACON Laboratories, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., bioMérieux SA, Chungdo Pharm Co., Ltd., F. Hoffmann-La Roche Ltd., Genetworx, LLC, Module Innovations Pvt. Ltd., QIAGEN GmbH, Randox Laboratories Ltd., Siemens Healthcare GmbH, T2 Biosystems, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Urinary Tract Infection Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Cystitis
Pyelonephritis
Urethritis
Vaginitis
Test
Cystoscopy Urinary Tract Infection Testing
Kidney & Bladder Ultrasound Urinary Tract Infection Testing
Laboratory Test
Non-Laboratory Test
Nuclear Scans Urinary Tract Infection Testing
Susceptibility Urinary Tract Infection Testing
Urinalysis Urinary Tract Infection Testing
Urine Culture Urinary Tract Infection Testing
Voiding Cystourethrogram (VCUG) Urinary Tract Infection Testing
End-Use
Accountable Care Organizations
General Practitioners
Hospital Emergency Departments
Hospital Laboratories
Reference Laboratories
Urgent Care
Urogynecologists
Urologists
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Urinary Tract Infection Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Urinary Tract Infection Testing Market?
3. What are the technology trends and regulatory frameworks in the Urinary Tract Infection Testing Market?
4. What is the market share of the leading vendors in the Urinary Tract Infection Testing Market?
5. Which modes and strategic moves are suitable for entering the Urinary Tract Infection Testing Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

194 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Urinary Tract Infection Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of urinary tract infections among geriartic and women
5.1.1.2. Prevalence of diabetes and kidney stones
5.1.1.3. Favorable investments by the government to increase rapid diagnostics
5.1.2. Restraints
5.1.2.1. Product recall and lack of awareness among the people
5.1.3. Opportunities
5.1.3.1. Increasing launch of combination drugs
5.1.3.2. Development of new imaging technologies and testing devices
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Urinary Tract Infection Testing Market, by Type
6.1. Introduction
6.2. Cystitis
6.3. Pyelonephritis
6.4. Urethritis
6.5. Vaginitis
7. Urinary Tract Infection Testing Market, by Test
7.1. Introduction
7.2. Cystoscopy Urinary Tract Infection Testing
7.3. Kidney & Bladder Ultrasound Urinary Tract Infection Testing
7.4. Laboratory Test
7.5. Non-Laboratory Test
7.6. Nuclear Scans Urinary Tract Infection Testing
7.7. Susceptibility Urinary Tract Infection Testing
7.8. Urinalysis Urinary Tract Infection Testing
7.9. Urine Culture Urinary Tract Infection Testing
7.10. Voiding Cystourethrogram (VCUG) Urinary Tract Infection Testing
8. Urinary Tract Infection Testing Market, by End-Use
8.1. Introduction
8.2. Accountable Care Organizations
8.3. General Practitioners
8.4. Hospital Emergency Departments
8.5. Hospital Laboratories
8.6. Reference Laboratories
8.7. Urgent Care
8.8. Urogynecologists
8.9. Urologists
9. Americas Urinary Tract Infection Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Urinary Tract Infection Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Urinary Tract Infection Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Accelerate Diagnostics, Inc.
13.1.2. ACON Laboratories, Inc.
13.1.3. Beckman Coulter, Inc.
13.1.4. Bio-Rad Laboratories, Inc.
13.1.5. bioMérieux SA
13.1.6. Chungdo Pharm Co., Ltd.
13.1.7. F. Hoffmann-La Roche Ltd.
13.1.8. Genetworx, LLC
13.1.9. Module Innovations Pvt. Ltd.
13.1.10. QIAGEN GmbH
13.1.11. Randox Laboratories Ltd.
13.1.12. Siemens Healthcare GmbH
13.1.13. T2 Biosystems, Inc.
13.1.14. Thermo Fisher Scientific Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. URINARY TRACT INFECTION TESTING MARKET RESEARCH PROCESS
FIGURE 2. URINARY TRACT INFECTION TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. URINARY TRACT INFECTION TESTING MARKET DYNAMICS
FIGURE 7. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2023 VS 2030 (%)
FIGURE 10. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us